Sanofi ADR
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $14,157,000 | $11,380,000 | $11,118,000 | $22,883,000 |
Gross Profit | 10,072,000 | 7,989,000 | 7,679,000 | 14,682,000 |
EBITDA | 4,247,000 | 2,510,000 | 2,861,500 | 1,644,500 |
EBIT | 3,768,000 | 1,628,000 | 2,032,000 | -1,346,500 |
Net Income | 2,815,000 | 1,113,000 | 1,133,000 | -555,000 |
Net Change In Cash | 14,157,000 | 11,380,000 | 11,118,000 | 22,883,000 |
Free Cash Flow | -504,000 | 4,587,000 | ||
Cash | 6,795,000 | -8,710,000 | 8,710,000 | |
Basic Shares | 1,253,000 | 1,253,800 | 1,248,800 | 1,253,600 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $46,033,000 | $45,389,000 | $39,175,000 | $37,369,000 |
Gross Profit | 31,797,000 | 31,697,000 | 26,920,000 | 25,212,000 |
EBITDA | 11,997,000 | 14,062,000 | 11,291,000 | 17,513,000 |
EBIT | 8,221,000 | 10,363,000 | 8,160,000 | 14,241,000 |
Net Income | 5,400,000 | 8,371,000 | 6,223,000 | 12,294,000 |
Net Change In Cash | 46,033,000 | 45,389,000 | 39,175,000 | 37,369,000 |
Free Cash Flow | 7,234,000 | 8,325,000 | 8,479,000 | 5,335,000 |
Cash | 8,710,000 | 12,736,000 | 10,098,000 | 13,915,000 |
Basic Shares | 1,256,400 | 1,256,900 | 1,257,900 | 1,260,100 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | $1.57 |
2024-06-30 | $0.93 |
2024-03-31 | $0.97 |
2023-12-31 | $0.89 |
